What is Evommune, Inc.'s Market Cap?

Evommune, Inc.'s Market Cap is $474.7M, based on as-reported figures from SEC (XBRL) filings.

What is Evommune, Inc.'s Enterprise Value?

Evommune, Inc.'s Enterprise Value is $274.9M, based on as-reported figures from SEC (XBRL) filings.

What is Evommune, Inc.'s Price / Sales?

Evommune, Inc.'s Price / Sales is 47.5×, based on as-reported figures from SEC (XBRL) filings.

What is Evommune, Inc.'s EV / Revenue?

Evommune, Inc.'s EV / Revenue is 27.5×, based on as-reported figures from SEC (XBRL) filings.

What is Evommune, Inc.'s EV / EBITDA?

Evommune, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Evommune, Inc.'s Revenue (TTM)?

Evommune, Inc.'s Revenue (TTM) is $10.0M, based on as-reported figures from SEC (XBRL) filings.

What is Evommune, Inc.'s Net Income (TTM)?

Evommune, Inc.'s Net Income (TTM) is -$94.7M, based on as-reported figures from SEC (XBRL) filings.

What is Evommune, Inc.'s EBITDA?

Evommune, Inc.'s EBITDA is -$101.3M, based on as-reported figures from SEC (XBRL) filings.

What is Evommune, Inc.'s Diluted EPS (TTM)?

Evommune, Inc.'s Diluted EPS (TTM) is -2.61, based on as-reported figures from SEC (XBRL) filings.

What is Evommune, Inc.'s EBITDA Margin?

Evommune, Inc.'s EBITDA Margin is -1012.9%, based on as-reported figures from SEC (XBRL) filings.

Evommune, Inc. (EVMN) Financial Statements

Evommune, Inc.

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00Y79N8B3

XNYS · usd

13.08▲ 0.81 (6.60%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close12.27

Day's Range12.01 – 13.35

52-Week Range10.47 – 33.25

Volume1.1M

Avg Volume466.8K

Share Statistics

Shares Outstanding

Employees48

ExchangeXNYS

Listed2025-11-06

Share count as of August 4, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Evommune, Inc. (EVMN)

What is Evommune, Inc.'s Market Cap?: Evommune, Inc.'s Market Cap is $474.7M, based on as-reported figures from SEC (XBRL) filings.
What is Evommune, Inc.'s Enterprise Value?: Evommune, Inc.'s Enterprise Value is $274.9M, based on as-reported figures from SEC (XBRL) filings.
What is Evommune, Inc.'s Price / Sales?: Evommune, Inc.'s Price / Sales is 47.5×, based on as-reported figures from SEC (XBRL) filings.
What is Evommune, Inc.'s EV / Revenue?: Evommune, Inc.'s EV / Revenue is 27.5×, based on as-reported figures from SEC (XBRL) filings.
What is Evommune, Inc.'s EV / EBITDA?: Evommune, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Evommune, Inc.'s Revenue (TTM)?: Evommune, Inc.'s Revenue (TTM) is $10.0M, based on as-reported figures from SEC (XBRL) filings.
What is Evommune, Inc.'s Net Income (TTM)?: Evommune, Inc.'s Net Income (TTM) is -$94.7M, based on as-reported figures from SEC (XBRL) filings.
What is Evommune, Inc.'s EBITDA?: Evommune, Inc.'s EBITDA is -$101.3M, based on as-reported figures from SEC (XBRL) filings.
What is Evommune, Inc.'s Diluted EPS (TTM)?: Evommune, Inc.'s Diluted EPS (TTM) is -2.61, based on as-reported figures from SEC (XBRL) filings.
What is Evommune, Inc.'s EBITDA Margin?: Evommune, Inc.'s EBITDA Margin is -1012.9%, based on as-reported figures from SEC (XBRL) filings.